{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:04:12Z","timestamp":1787061852209,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10528-023-10381-1","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:02:30Z","timestamp":1682690550000},"page":"2481-2495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MiR-1275 Targeting SPARC Promotes Gambogic Acid-Induced Inhibition of Gastric Cancer"],"prefix":"10.1007","volume":"61","author":[{"given":"Ang","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"5","key":"10381_CR1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/ijms21051723","volume":"21","author":"Z Ali Syeda","year":"2020","unstructured":"Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ (2020) Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci 21(5):1723. https:\/\/doi.org\/10.3390\/ijms21051723","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10381_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/jci12939","volume":"107","author":"AD Bradshaw","year":"2001","unstructured":"Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Investig 107(9):1049\u20131054. https:\/\/doi.org\/10.1172\/jci12939","journal-title":"J Clin Investig"},{"issue":"1","key":"10381_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cam4.1274","volume":"7","author":"N Charalampakis","year":"2018","unstructured":"Charalampakis N, Economopoulou P, Kotsantis I, Tolia M, Schizas D, Liakakos T et al (2018) Medical management of gastric cancer: a 2017 update. Cancer Med 7(1):123\u2013133. https:\/\/doi.org\/10.1002\/cam4.1274","journal-title":"Cancer Med"},{"issue":"24","key":"10381_CR4","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/ijms20246249","volume":"20","author":"M Correia de Sousa","year":"2019","unstructured":"Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M (2019) Deciphering miRNAs\u2019 Action through miRNA editing. Int J Mol Sci 20(24):6249. https:\/\/doi.org\/10.3390\/ijms20246249","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10381_CR5","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.febslet.2015.06.038","volume":"589","author":"IO Fawzy","year":"2015","unstructured":"Fawzy IO, Hamza MT, Hosny KA, Esmat G, El Tayebi HM, Abdelaziz AI (2015) miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Lett 589(17):2257\u20132265. https:\/\/doi.org\/10.1016\/j.febslet.2015.06.038","journal-title":"FEBS Lett"},{"issue":"39","key":"10381_CR6","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.2174\/1381612820666140619123255","volume":"20","author":"J Feng","year":"2014","unstructured":"Feng J, Tang L (2014) SPARC in tumor pathophysiology and as a potential therapeutic target. Curr Pharm Des 20(39):6182\u20136190. https:\/\/doi.org\/10.2174\/1381612820666140619123255","journal-title":"Curr Pharm Des"},{"key":"10381_CR7","doi-asserted-by":"publisher","first-page":"775743","DOI":"10.3389\/fmolb.2021.775743","volume":"8","author":"ZW Gao","year":"2021","unstructured":"Gao ZW, Liu C, Yang L, He T, Wu XN, Zhang HZ et al (2021) SPARC Overexpression promotes liver cancer cell proliferation and tumor growth. Front Mol Biosci 8:775743. https:\/\/doi.org\/10.3389\/fmolb.2021.775743","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10381_CR8","doi-asserted-by":"publisher","first-page":"18312","DOI":"10.1038\/s41598-022-21492-x","volume":"12","author":"S Gupta","year":"2022","unstructured":"Gupta S, Panda PK, Luo W, Hashimoto RF, Ahuja R (2022) Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer. Sci Rep 12(1):18312. https:\/\/doi.org\/10.1038\/s41598-022-21492-x","journal-title":"Sci Rep"},{"issue":"1","key":"10381_CR9","doi-asserted-by":"publisher","first-page":"152725","DOI":"10.1016\/j.prp.2019.152725","volume":"216","author":"X He","year":"2020","unstructured":"He X, Shu Y (2020) miR-452 promotes the development of gastric cancer via targeting EPB41L3. Pathol Res Pract 216(1):152725. https:\/\/doi.org\/10.1016\/j.prp.2019.152725","journal-title":"Pathol Res Pract"},{"key":"10381_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2017.03.019","volume":"177","author":"S Hu","year":"2017","unstructured":"Hu S, Zheng Q, Wu H, Wang C, Liu T, Zhou W (2017) miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sci 177:15\u201319. https:\/\/doi.org\/10.1016\/j.lfs.2017.03.019","journal-title":"Life Sci"},{"issue":"6","key":"10381_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bcpt.13090","volume":"123","author":"L Liang","year":"2018","unstructured":"Liang L, Zhang Z, Qin X, Gao Y, Zhao P, Liu J et al (2018) Gambogic acid inhibits melanoma through regulation of miR-199a-3p\/ZEB1 signalling. Basic Clin Pharmacol Toxicol 123(6):692\u2013703. https:\/\/doi.org\/10.1111\/bcpt.13090","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10381_CR12","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.2147\/cmar.S269768","volume":"12","author":"D Lin","year":"2020","unstructured":"Lin D, Lin X, He T, Xie G (2020) Gambogic acid inhibits the progression of gastric cancer via circRNA_ASAP2\/miR-33a-5p\/CDK7 axis. Cancer Manag Res 12:9221\u20139233. https:\/\/doi.org\/10.2147\/cmar.S269768","journal-title":"Cancer Manag Res"},{"key":"10381_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.12.049","volume":"646","author":"MD Liu","year":"2018","unstructured":"Liu MD, Wu H, Wang S, Pang P, Jin S, Sun CF et al (2018) miR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7. Gene 646:1\u20137. https:\/\/doi.org\/10.1016\/j.gene.2017.12.049","journal-title":"Gene"},{"key":"10381_CR14","doi-asserted-by":"publisher","first-page":"10385","DOI":"10.2147\/ijn.S277645","volume":"15","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen Y, Lin L, Li H (2020) Gambogic acid as a candidate for cancer therapy: a review. Int J Nanomed 15:10385\u201310399. https:\/\/doi.org\/10.2147\/ijn.S277645","journal-title":"Int J Nanomed"},{"issue":"1","key":"10381_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1186\/s12885-019-5929-1","volume":"19","author":"JW Mei","year":"2019","unstructured":"Mei JW, Yang ZY, Xiang HG, Bao R, Ye YY, Ren T et al (2019) MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1. BMC Cancer 19(1):740. https:\/\/doi.org\/10.1186\/s12885-019-5929-1","journal-title":"BMC Cancer"},{"issue":"5","key":"10381_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/carcin\/bgu072","volume":"35","author":"GP Nagaraju","year":"2014","unstructured":"Nagaraju GP, Dontula R, El-Rayes BF, Lakka SS (2014) Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. Carcinogenesis 35(5):967\u2013973. https:\/\/doi.org\/10.1093\/carcin\/bgu072","journal-title":"Carcinogenesis"},{"key":"10381_CR17","doi-asserted-by":"publisher","first-page":"113519","DOI":"10.1016\/j.biopha.2022.113519","volume":"153","author":"Q Nian","year":"2022","unstructured":"Nian Q, Li J, Han Z, Liang Q, Liu M, Yang C et al (2022) SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression. Biomed Pharmacother 153:113519. https:\/\/doi.org\/10.1016\/j.biopha.2022.113519","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10381_CR18","doi-asserted-by":"publisher","first-page":"11900","DOI":"10.3892\/mmr.2021.11900","volume":"23","author":"Z Pan","year":"2021","unstructured":"Pan Z, Xie R, Song W, Gao C (2021) MicroRNA-592 promotes cell proliferation, migration and invasion in colorectal cancer by directly targeting SPARC. Mol Med Rep 23(4):11900. https:\/\/doi.org\/10.3892\/mmr.2021.11900","journal-title":"Mol Med Rep"},{"key":"10381_CR19","doi-asserted-by":"publisher","first-page":"e10462","DOI":"10.7717\/peerj.10462","volume":"9","author":"W Qi","year":"2021","unstructured":"Qi W, Zhang Q (2021) Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer. PeerJ 9:e10462. https:\/\/doi.org\/10.7717\/peerj.10462","journal-title":"PeerJ"},{"key":"10381_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.matbio.2016.02.001","volume":"52\u201354","author":"EM Rosset","year":"2016","unstructured":"Rosset EM, Bradshaw AD (2016) SPARC\/osteonectin in mineralized tissue. Matrix Biol 52\u201354:78\u201387. https:\/\/doi.org\/10.1016\/j.matbio.2016.02.001","journal-title":"Matrix Biol"},{"issue":"6","key":"10381_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/jso.23425","volume":"108","author":"T Sato","year":"2013","unstructured":"Sato T, Oshima T, Yamamoto N, Yamada T, Hasegawa S, Yukawa N et al (2013) Clinical significance of SPARC gene expression in patients with gastric cancer. J Surg Oncol 108(6):364\u2013368. https:\/\/doi.org\/10.1002\/jso.23425","journal-title":"J Surg Oncol"},{"issue":"18","key":"10381_CR22","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1080\/14786419.2017.1366478","volume":"32","author":"YM Shaalan","year":"2018","unstructured":"Shaalan YM, Handoussa H, Youness RA, Assal RA, El-Khatib AH, Linscheid MW et al (2018) Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma. Nat Prod Res 32(18):2217\u20132220. https:\/\/doi.org\/10.1080\/14786419.2017.1366478","journal-title":"Nat Prod Res"},{"issue":"10251","key":"10381_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396(10251):635\u2013648. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5","journal-title":"Lancet"},{"issue":"4","key":"10381_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12079-016-0351-9","volume":"10","author":"KY Sun","year":"2016","unstructured":"Sun KY, Peng T, Chen Z, Huang J, Zhou XH (2016) MicroRNA-1275 suppresses cell growth, and retards G1\/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5. J Cell Commun Signal 10(4):305\u2013314. https:\/\/doi.org\/10.1007\/s12079-016-0351-9","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"10381_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA"},{"key":"10381_CR26","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.12659\/msm.916475","volume":"25","author":"Z Tan","year":"2019","unstructured":"Tan Z (2019) Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit 25:3537\u20133541. https:\/\/doi.org\/10.12659\/msm.916475","journal-title":"Med Sci Monit"},{"issue":"1","key":"10381_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3892\/ol.2016.5433","volume":"13","author":"Q Tang","year":"2017","unstructured":"Tang Q, Lu M, Zhou H, Chen D, Liu L (2017) Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity. Oncol Lett 13(1):384\u2013388. https:\/\/doi.org\/10.3892\/ol.2016.5433","journal-title":"Oncol Lett"},{"issue":"5","key":"10381_CR28","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.3892\/mmr.2019.10697","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Sui Y, Tao Y (2019) Gambogic acid increases the sensitivity to paclitaxel in drug-resistant triple-negative breast cancer via the SHH signaling pathway. Mol Med Rep 20(5):4515\u20134522. https:\/\/doi.org\/10.3892\/mmr.2019.10697","journal-title":"Mol Med Rep"},{"issue":"7","key":"10381_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1142\/s0192415x20500780","volume":"48","author":"S Wang","year":"2020","unstructured":"Wang S, Long S, Deng Z, Wu W (2020) Positive role of chinese herbal medicine in cancer immune regulation. Am J Chin Med 48(7):1577\u20131592. https:\/\/doi.org\/10.1142\/s0192415x20500780","journal-title":"Am J Chin Med"},{"key":"10381_CR30","doi-asserted-by":"publisher","first-page":"104276","DOI":"10.1016\/j.yexmp.2019.104276","volume":"110","author":"J Xu","year":"2019","unstructured":"Xu J, Yang S, Gu X, Shen H, Wang L, Xu W et al (2019) SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma. Exp Mol Pathol 110:104276. https:\/\/doi.org\/10.1016\/j.yexmp.2019.104276","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10381_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1756-9966-29-59","volume":"29","author":"J Yin","year":"2010","unstructured":"Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y et al (2010) Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res 29(1):59. https:\/\/doi.org\/10.1186\/1756-9966-29-59","journal-title":"J Exp Clin Cancer Res"},{"key":"10381_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2147\/ijn.S231448","volume":"15","author":"D Zhang","year":"2020","unstructured":"Zhang D, Chu Y, Qian H, Qian L, Shao J, Xu Q et al (2020) Antitumor activity of thermosensitive hydrogels packaging gambogic acid nanoparticles and tumor-penetrating peptide iRGD against gastric cancer. Int J Nanomed 15:735\u2013747. https:\/\/doi.org\/10.2147\/ijn.S231448","journal-title":"Int J Nanomed"},{"issue":"4","key":"10381_CR33","doi-asserted-by":"publisher","first-page":"e22721","DOI":"10.1002\/jbt.22721","volume":"35","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liang L, Cao G (2021) Critical role of miR-26a-5p\/Wnt5a signaling in gambogic acid-induced inhibition of gastric cancer. J Biochem Mol Toxicol 35(4):e22721. https:\/\/doi.org\/10.1002\/jbt.22721","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"10381_CR34","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.3892\/etm.2019.7912","volume":"18","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Ma J (2019) Gambogic acid suppresses colon cancer cell activity in vitro. Exp Ther Med 18(4):2917\u20132923. https:\/\/doi.org\/10.3892\/etm.2019.7912","journal-title":"Exp Ther Med"},{"issue":"2","key":"10381_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.21037\/atm-20-7272","volume":"9","author":"T Zou","year":"2021","unstructured":"Zou T, Gao Y, Qie M (2021) MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC. Ann Transl Med 9(2):125. https:\/\/doi.org\/10.21037\/atm-20-7272","journal-title":"Ann Transl Med"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10381-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:13:27Z","timestamp":1700651607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10381-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10381"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10381-1","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"29 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research has been approved by the Ethics Committee of Wuhan Hospital of Traditional Chinese Medicine (approval number: 2022013, Wuhan, China). The processing of clinical samples is in strict compliance with the ethical standards of the Declaration of Helsinki. All patients provided their written informed consent. The procedures executed in the animal study were approved by the animal ethics committee of Wuhan Hospital of Traditional Chinese Medicine (approval number: WHTCM2021174). All animal experiments comply with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients signed a written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}